12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)
NCT00145470
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
326
Enrollment
INDUSTRY
Sponsor class
Conditions
Bipolar Disorder
Interventions
DRUG:
Asenapine
DRUG:
Placebo
Sponsor
Organon and Co